Sharecare Reschedules Issuance Of Q4 And FY23 Earnings Release And Investor Conference Call For After Market Close On Thursday, March 28, 2024
Portfolio Pulse from Benzinga Newsdesk
Sharecare (NASDAQ:SHCR), a digital health company, has postponed its Q4 and FY23 earnings release and investor conference call from March 13, 2024, to after market close on March 28, 2024. The company will also file a Form 12b-25 with the SEC, indicating a delay in filing its Form 10-K, but expects to meet the 15-day extension period. No changes to previously reported financials are anticipated.
March 12, 2024 | 1:10 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Sharecare has rescheduled its Q4 and FY23 earnings release to March 28, 2024, and will file a Form 12b-25 for a delay in its Form 10-K filing, with no expected changes to financials.
The postponement of the earnings release and the filing of Form 12b-25 might cause short-term uncertainty among investors, potentially affecting the stock's price. However, the company's statement that no changes to previously reported financials are expected could mitigate negative impacts, leading to a neutral short-term price direction.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100